Heart valve tissue engineering: how far is the bedside from the bench?
- 24 September 2015
- journal article
- review article
- Published by Cambridge University Press (CUP) in Expert Reviews in Molecular Medicine
- Vol. 17, e16
Abstract
Heart disease, including valve pathologies, is the leading cause of death worldwide. Despite the progress made thanks to improving transplantation techniques, a perfect valve substitute has not yet been developed: once a diseased valve is replaced with current technologies, the newly implanted valve still needs to be changed some time in the future. This situation is particularly dramatic in the case of children and young adults, because of the necessity of valve growth during the patient's life. Our review focuses on the current status of heart valve (HV) therapy and the challenges that must be solved in the development of new approaches based on tissue engineering. Scientists and physicians have proposed tissue-engineered heart valves (TEHVs) as the most promising solution for HV replacement, especially given that they can help to avoid thrombosis, structural deterioration and xenoinfections. Lastly, TEHVs might also serve as a model for studying human valve development and pathologies.Keywords
This publication has 211 references indexed in Scilit:
- Decellularization of Human and Porcine Lung Tissues for Pulmonary Tissue EngineeringThe Annals of Thoracic Surgery, 2013
- Organ engineering – combining stem cells, biomaterials, and bioreactors to produce bioengineered organs for transplantationBioEssays, 2012
- Recruitment of bone marrow-derived valve interstitial cells is a normal homeostatic processJournal of Molecular and Cellular Cardiology, 2011
- Endothelial Cell Micropatterning: Methods, Effects, and ApplicationsAnnals of Biomedical Engineering, 2011
- EMT-Inducing Biomaterials for Heart Valve Engineering: Taking Cues from Developmental BiologyJournal of Cardiovascular Translational Research, 2011
- The role of organ level conditioning on the promotion of engineered heart valve tissue development in-vitro using mesenchymal stem cellsBiomaterials, 2010
- Endothelial Differentiation of Adipose-Derived Stem Cells: Effects of Endothelial Cell Growth Supplement and Shear ForceJournal of Surgical Research, 2009
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- Tissue engineering applications to vascular bypass graft development: The use of adipose-derived stem cellsJournal of Vascular Surgery, 2007
- Aortic valve sclerosis is associatedwith systemic endothelial dysfunctionJACC, 2003